Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

Novartis has announced new long-term Social Impact & Sustainability (SI&S) targets and goals, reinforcing our commitment to go beyond breakthroughs to maximize the impact of our medicines to support inclusive, resilient healthcare systems worldwide.

People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.

With extensive experience in public health management, having worked for the International Red Cross, among others, and as a doctor in emergency situations on the ground in Africa and Asia— Ann Aerts discusses the Novartis Foundation's new leprosy strategy.

Novartis works tirelessly with third-party organizations to improve access to cancer care.

In Australia, a country where skin cancer rates remain high, cancer survivor Malcolm Caddies is on a mission to prevent the risks of sun exposure.